• OPEN AN ACCOUNT
Indian Indices
Sensex
78,071.36 505.20
( 0.65%)
Global Indices
Nasdaq
47,737.88 215.33
(0.45%)
Dow Jones
6,814.47 53.45
(0.79%)
Hang Seng
54,146.56 1,417.84
(2.69%)
Nikkei 225
10,249.54 -35.21
(-0.34%)
Forex
USD-INR
91.85 0.10
(0.11%)
EUR-INR
106.60 0.13
(0.12%)
GBP-INR
123.04 0.62
(0.51%)
JPY-INR
0.58 0.00
(-0.25%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
205.5515954
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
34.78
686.83
EPS(TTM)
Face Value()
Div & Yield %
16.76
10
0.26
 

tmt (i) ltd
Rajratan Global gains after Q3 PAT climbs 122% YoY to Rs 21 crore
Jan 21,2026
During the quarter, profit before tax (PBT) climbed 116.36% to Rs 26.70 crore, compared with Rs 12.34 crore in Q3 FY25.

Total expenses jumped 33.39% to Rs 275.36 crore in Q3 FY26, compared with Rs 206.43 crore in Q3 FY25. The cost of material consumed stood at Rs 175.07 crore (up 23% YoY), employee benefit expenses were Rs 13.85 crore (down 18.78% YoY) and finance costs stood at Rs 7.23 crore (down 8.13% YoY) during the period under review.

Meanwhile, the board of directors, at its meeting held on Wednesday, 21 January 2026, approved the reappointment of Yashovardhan Chordia as chief executive officer & deputy managing director of the company, liable to retire by rotation, for a period of three years with effect from 21 April 2026 to 20 April 2029 (both days inclusive), subject to the approval of the shareholders.

Rajratan Global Wire is engaged in the manufacturing of bead wire, a high-carbon steel wire utilized in the production of tires.